Нейроиммунные биомаркеры как молекулярные индикаторы развития предгипертонии и гипертонической болезни

M. A. Gruden; V. V. Sherstnev

doi:10.25557/2310-0435.2022.03.83-84

Neuroimmune biomarkers as molecular indicators of the development of prehypertension and hypertension

Authors

M. A. Gruden P.K.Anokhin Institute of Normal Physiology, Moscow, Russian Federation
V. V. Sherstnev P.K.Anokhin Institute of Normal Physiology, Moscow, Russian Federation

DOI:

https://doi.org/10.25557/2310-0435.2022.03.83-84

Keywords:

Neuroimmunopathology

Abstract

Conference abstract

Downloads

pdf (Russian)

Published

2022-10-14

Issue

Vol. 20 No. 3 (2022): Pathogenesis

Section

Brief reports

How to Cite

Gruden MA, Sherstnev VV. Neuroimmune biomarkers as molecular indicators of the development of prehypertension and hypertension. Патогенез. 2022;20(3):83-84. doi:10.25557/2310-0435.2022.03.83-84

Download Citation

Most read articles by the same author(s)

M. A. Gruden, T. V. Davydova, Differential detection of autoantibodies to Aβ25-35 in patients with different duration of Alzheimer’s disease course , Patogenez (Pathogenesis): Vol. 16 No. 3 (2018): Pathogenesis
M. A. Gruden, A. M. Ratmirov, Z. I. Storozheva, Cooperative effects of expression of apoptosis-regulating genes in formation of spatial memory , Patogenez (Pathogenesis): Vol. 18 No. 3 (2020): Pathogenesis
O. A. Solovieva, M. A. Gruden, V. V. Sherstnev, Effect of chronic intranasal administration of α-synuclein oligomers on motor activity and anxiety in adult and middle-aged mice , Patogenez (Pathogenesis): Vol. 17 No. 3 (2019): Pathogenesis
O. A. Solovieva, M. A. Gruden, I. A. Kalinin, A. . Ratmirov, V. V. Sherstnev, Effect of a composite mixture of native and oligomeric forms of the α-synuclein protein upon intranasal administration on aging mouse behavior , Patogenez (Pathogenesis): Vol. 16 No. 4 (2018): Pathogenesis
V. V. Sherstnev, M. A. Gruden, O. V. Senko, V. P. Karlina, A. V. Kuznetsova, V. M. Ryzhov, Gender peculiarities of interrelations between cardiovascular risk factors and development of prehypertension , Patogenez (Pathogenesis): Vol. 16 No. 3 (2018): Pathogenesis
V. G. Kucheryanu, N. A. Voronina, E. V. Bocharov, L. A. Vetrile, V. V. Goloborshcheva, O. A. Bocharova, T. V. Davydova, M. A. Gruden, R. D. Sewell, I. G. Kapitsa, T. A. Voronina, The role of neuroinflammation in the death mechanisms of nigrostriatal dopaminergic neurons in Parkinson’s disease , Patogenez (Pathogenesis): Vol. 20 No. 3 (2022): Pathogenesis
M. A. Gruden, V. I. Inokenteva, O. A. Solovieva, N. P. Mikhailova, A. M. Ratmirov, Z. I. Storozheva, Сhanges in cognitive processes and transcriptional activity of the S100A6 and ASCL1 genes at different times after chronic administration of amyloidogenic alpha-synuclein oligomers , Patogenez (Pathogenesis): Vol. 22 No. 1 (2024): Патогенез
N. P. Mikhaylova, A. M. Ratmirov, M. A. Gruden, V. V. Sherstnev, Dynamic changes of gait parameters in C57BL/6J mice after intranasal administration of oligomeric forms of alpha-synuclein protein , Patogenez (Pathogenesis): Vol. 21 No. 1 (2023): Pathogenesis
M. A. Gruden, Robert D.E. Sewell, Autoantibodies to α-synuclein protein and its amyloidogenic aggregates in humoral mechanisms of immunity in Parkinson's disease and experimental modeling , Patogenez (Pathogenesis): Vol. 20 No. 3 (2022): Pathogenesis

Neuroimmune biomarkers as molecular indicators of the development of prehypertension and hypertension

Authors

DOI:

Keywords:

Abstract

Downloads

Published

Issue

Section

How to Cite

Most read articles by the same author(s)

Subscription

Language

Information

Make a Submission

Developed By